Serum- Free Culture of Hybridoma Cell Line 183B2 with Ovarian Carcinoma Monoclonal Antibody

程洪艳,冯捷,崔恒,成夜霞,付天云,昌晓红,叶雪
DOI: https://doi.org/10.3969/j.issn.1672-1861.2004.05.016
2004-01-01
Abstract:Objective To culture the hybridoma cells in serum-free medium (SFM) and to purify the monoclonal antibody against ovarian carcinoma from the culture supernatant in vitro.Methods Ovarian carcinoma hybridoma cell 183B2 was cultured in Hybridoma-SFM (H-SFM), and the control was cultured with RPMI1640 medium supplemented with 10% fetal bovine serum. The characters of cell growth and antibody production were compared. The protein was purified from the culture supernatant with Protein A affinity chromatography.Results Ovarian carcinoma hybridoma cell 183B2 was successfully adapted to grow in H-SFM. Cell growth rate, monoclonal antibody (Mab) production and Mab activity were similar between the H-SFM and the control. The peak of IgG, which was approximately 50 mg.L -1 /10 6 cells, was obtained after 4 days culture. About 10 mg.L -1 (cell culture supernatant) of the Mab could be achieved.Conclusions The 183B2 hybridoma cells can be cultured in H-SFM and the Protein A chromatography can be applied to purify the Mab from the cell culture supernatant. These results obtained in this study offer practical methods for scale-up Mab production.
What problem does this paper attempt to address?